...
首页> 外文期刊>Oncogenesis. >Tumor-derived exosomes induce PD1 + macrophage population in human gastric cancer that promotes disease progression
【24h】

Tumor-derived exosomes induce PD1 + macrophage population in human gastric cancer that promotes disease progression

机译:肿瘤来源的外泌体在人胃癌中诱导PD1 +巨噬细胞种群,从而促进疾病进展

获取原文

摘要

Macrophages constitute a major component of tumor-infiltrating immune cells. M2 macrophages have been reported to promote tumor progression through promoting tumor angiogenesis and metastasis and regulating T-cell function. Here, we identified a protumorigenic subset of macrophages that constitutively expressed programmed cell death 1 (PD1) and accumulated in advanced-stage gastric cancer (GC). These PD1+ tumor-associated macrophages (TAMs) exhibited an M2-like surface profile, with a significant increase in the expression of CD206, IL-10, and CCL1, and a clear decrease in the expression of MHC class II, CD64, and IL-12 and the ability to phagocytose ovalbumin. Moreover, PD1+ TAMs can suppress CD8+ T-cell function and this immunosuppressive activity can effectively be enhanced upon triggering PD1 signal. GC-derived exosomes effectively educated monocytes to differentiate into PD1+ TAMs with M2 phenotypic and functional characteristics. Together, our results are the first to show that GC-derived exosomes can effectively induce PD1+ TAM generation, and these cells can produce a large number of IL-10, impair CD8+ T-cell function, and thereby create conditions that promote GC progression. Thus, methods in which immunotherapy is combined with targeting PD1+ TAMs and tumor-derived exosomes should be used to restore immune function in GC patients.
机译:巨噬细胞是肿瘤浸润免疫细胞的主要成分。据报道,M2巨噬细胞通过促进肿瘤血管生成和转移以及调节T细胞功能来促进肿瘤进展。在这里,我们确定了组成性表达程序性细胞死亡1(PD1)并在晚期胃癌(GC)中积累的巨噬细胞的致瘤子集。这些PD1 +肿瘤相关巨噬细胞(TAM)表现出类似M2的表面轮廓,其中CD206,IL-10和CCL1的表达显着增加,而II类,MHC,CD64和IL的表达则明显减少-12和吞噬卵清蛋白的能力。此外,PD1 + TAMs可以抑制CD8 + T细胞功能,触发PD1信号后可以有效增强这种免疫抑制活性。 GC衍生的外泌体有效地教育了单核细胞,使其分化为具有M2表型和功能特征的PD1 + TAM。在一起,我们的结果首次表明,GC衍生的外泌体可以有效地诱导PD1 + TAM的产生,并且这些细胞可以产生大量的IL-10,损害CD8 + T细胞的功能,从而创造出促进GC进程的条件。因此,应将免疫疗法与靶向PD1 + TAM和肿瘤来源的外泌体相结合的方法用于恢复GC患者的免疫功能。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号